Cystic Fibrosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You (or your legal guardian) are willing and able to sign a consent form agreeing to take part in the study
- You are willing and able to attend all scheduled study visits and follow the study requirements
- You are 12 years of age or older at your first study visit
- If you are someone who could become pregnant, you must not be pregnant at the start of the study and must not plan to become pregnant during the 12-month study period
- You have a confirmed diagnosis of cystic fibrosis (CF), shown by symptoms of CF plus either: a sweat chloride test result of 60 or above, two known CF-causing gene changes, or one known CF-causing gene change plus a second gene change and a sweat result of 30 or above (confirm with trial site)
- Your health has been stable with no significant changes in the 28 days before your first visit
- You have never had a lung transplant
Who may not be able to join:
- You are genetically eligible for a CFTR modulator medication (a specific type of CF treatment) based on approved guidelines, or you have used one within 28 days before your first visit and plan to continue or restart it during the study
- You have taken any experimental/investigational drug within 90 days before your first visit
- You are currently taking part in another clinical trial involving an experimental drug or medical device
- You have started any new long-term medication (such as ibuprofen, azithromycin, or certain inhaled antibiotics) within the 28 days before your first visit
- You have used antibiotics (by mouth, inhaled, or through a drip) or steroid medicines for breathing/lung symptoms within the 28 days before your first visit
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Deepika Polineni, MD, MPH, Washington University School of Medicine
Phone: 206-884-1681
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in ppFEV1 at 12 months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.